Europe Analgesics Market Size is USD 14.08 Billion by 2026

Europe Analgesics Market (By Drug Type: Opioid, Non-opioid, Compound Medication; By Route of Administration: Oral, Parenteral, Transdermal, Others; By Application: Musculoskeletal, Surgical and Trauma, Cancer, Neuropathic, Migraine, Obstetrical, Fibromyalgia, Pain Due to Burns, Dental/Facial, Pediatric, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Industry Size, Share, Growth, Trends 2025 to 2035

Report Code : 1611 | Published : 08 Jun 2026 | Delivery : Immediate | Format : Excel | Author : Aditi Shivarkar, Aman Singh

Revenue,

USD 13.32 Bn

Forecast Year,

USD 23.19 Bn

CAGR, 2026 - 2035

5.70%

Report Coverage

Europe

Download Databook

The Europe analgesics market size was estimated at USD 13.32 billion in 2025 and is projected to be worth around USD 23.19 billion by 2035, is expanding at a CAGR of 5.70% from 2026 to 2035. Growing due to an aging population and rising cases of musculoskeletal and inflammatory disorders.

Europe America Analgesics Market Statical Scope

Reports Attributes	Statistics
Market Size in 2025	USD 13.32 Billion
Market Size in 2026	USD 14.08 Billion
Market Size by 2035	USD 23.19 Billion
CAGR 2026 to 2035	5.70%
Base Year	2025
Forecast Period	2026 to 2035

Due to consumer preference for safer options, the market is seeing an increase in demand for natural and over-the-counter pain relief products. Innovation in alternative therapies is being stimulated by strict regulations on opioids. Additionally, the need for treatments for chronic pain is increasing due to aging populations.

The Europe analgesics market is fueled by an increase in the prevalence of musculoskeletal conditions and arthritis, favorable healthcare regulations, and a growing demand for safer, non-addictive analgesics. Alternative treatments are becoming more popular due to government regulations encouraging responsible opioid use.

Segments	Shares (%)
Non-opioid	32%
Opioid	48%
Compound Medication	20%

Opioid- Opioid segment is dominating with a market share of 32% driven by controlled use in severe pain cases. Stringent monitoring frameworks are limiting but stabilizing usage.
Non-opioid - The Non opioid segment is dominating with a market share of 48% driven by strict regulations on opioid usage.
Compound Medication- Compound medication segment is fastest growing, with the market share of 20% driven by personalized treatment demand. Increasing adoption of customized formulations is enhancing growth potential.

Segments	Shares (%)
Oral	55%
Parenteral	20%
Transdermal	15%
Others	10%

Oral- Oral route is dominating with a share of 55% driven by convenience and widespread usage.
Parenteral- Parenteral route is notable with a market share of 20% driven by hospital-based administration. Growth in clinical settings is maintaining steady demand.
Transdermal- The transdermal route is the fastest growing with a market share of 15%, driven by innovation in drug delivery systems.

Segments	Shares (%)
Musculoskeletal	24%
Surgical and Trauma	16%
Cancer	10%
Neuropathic	10%
Migraine	8%
Dental/Facial	6%
Obstetrical	5%
Fibromyalgia	5%
Pediatric	5%
Others	5%
Pain Due to Burns	4%

Musculoskeletal - Musculoskeletal segment is dominating with a market share of 24% driven by the aging population.
Surgical and Trauma - Surgical and trauma segment is fastest growing, with a market share of 16% driven by increasing surgeries.
Cancer - Caner segment is notable with a market share of 10% driven by oncology care demand. Improved access to cancer treatment is sustaining segment growth.

Segments	Shares (%)
Hospital Pharmacies	38%
Retail Pharmacies	45%
Online Pharmacies	17%

Hospital Pharmacies- Hospital pharmacies segment is notable with a market share of 38% driven by institutional demand.
Retail Pharmacies- Retail pharmacies is dominating with a market share of 45% driven by high OTC accessibility. Strong pharmacy networks are enhancing product availability.

Top Companies in the Europe Analgesics Market

Bayer AG
Endo International plc
Assertio Holdings, Inc.
Janssen Global Services, LLC
GSK plc
AbbVie Inc.
Novartis AG
Viatris Inc.
Teva Pharmaceutical Industries Ltd.

Segments Covered in the Report

By Drug Type

Opioid
Non-opioid
Compound Medication

By Route of Administration

Oral
Parenteral
Transdermal
Others

By Application

Musculoskeletal
Surgical and Trauma
Cancer
Neuropathic
Migraine
Obstetrical
Fibromyalgia
Pain Due to Burns
Dental/Facial
Pediatric
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

List of Tables & Figures

List of Tables

Table 1: Europe Analgesics Market Size, by Drug Type, 2025-2035 (USD Billion)
Table 2: Europe Opioid Market Size, 2025-2035 (USD Billion)
Table 3: Europe Non-opioid Market Size, 2025-2035 (USD Billion)
Table 4: Europe Compound Medication Market Size, 2025-2035 (USD Billion)
Table 5: Europe Analgesics Market Size, by Route of Administration, 2025-2035 (USD Billion)
Table 6: Europe Oral Market Size, 2025-2035 (USD Billion)
Table 7: Europe Parenteral Market Size, 2025-2035 (USD Billion)
Table 8: Europe Transdermal Market Size, 2025-2035 (USD Billion)
Table 9: Europe Others Market Size, 2025-2035 (USD Billion)
Table 10: Europe Analgesics Market Size, by Application, 2025-2035 (USD Billion)
Table 11: Europe Musculoskeletal Market Size, 2025-2035 (USD Billion)
Table 12: Europe Surgical and Trauma Market Size, 2025-2035 (USD Billion)
Table 13: Europe Cancer Market Size, 2025-2035 (USD Billion)
Table 14: Europe Neuropathic Market Size, 2025-2035 (USD Billion)
Table 15: Europe Migraine Market Size, 2025-2035 (USD Billion)
Table 16: Europe Obstetrical Market Size, 2025-2035 (USD Billion)
Table 17: Europe Fibromyalgia Market Size, 2025-2035 (USD Billion)
Table 18: Europe Pain Due to Burns Market Size, 2025-2035 (USD Billion)
Table 19: Europe Dental/Facial Market Size, 2025-2035 (USD Billion)
Table 20: Europe Pediatric Market Size, 2025-2035 (USD Billion)
Table 21: Europe Others Market Size, 2025-2035 (USD Billion)
Table 22: Europe Analgesics Market Size, by Distribution Channel, 2025-2035 (USD Billion)
Table 23: Europe Hospital Pharmacies Market Size, 2025-2035 (USD Billion)
Table 24: Europe Retail Pharmacies Market Size, 2025-2035 (USD Billion)
Table 25: Europe Online Pharmacies Market Size, 2025-2035 (USD Billion)
Table 26: Germany Analgesics Market Size, 2025-2035 (USD Billion)
Table 27: France Analgesics Market Size, 2025-2035 (USD Billion)
Table 28: U.K. Analgesics Market Size, 2025-2035 (USD Billion)
Table 29: Italy Analgesics Market Size, 2025-2035 (USD Billion)
Table 30: Spain Analgesics Market Size, 2025-2035 (USD Billion)
Table 31: Rest of Europe Analgesics Market Size, 2025-2035 (USD Billion)
Table 32: Europe Market Share, by Drug Type, 2025 (%)
Table 33: Europe Market Share, by Route of Administration, 2025 (%)
Table 34: Europe Market Share, by Application, 2025 (%)
Table 35: Europe Market Share, by Distribution Channel, 2025 (%)

List of Figures

Figure 1: Europe Analgesics Market Share, by Drug Type, 2025 (%)
Figure 2: Europe Analgesics Market Share, by Route of Administration, 2025 (%)
Figure 3: Europe Analgesics Market Share, by Application, 2025 (%)
Figure 4: Europe Analgesics Market Share, by Distribution Channel, 2025 (%)
Figure 5: Europe Analgesics Market Forecast, 2025-2035 (USD Billion)
Figure 6: Europe Opioid Market Forecast, 2025-2035 (USD Billion)
Figure 7: Europe Non-opioid Market Forecast, 2025-2035 (USD Billion)
Figure 8: Europe Compound Medication Market Forecast, 2025-2035 (USD Billion)
Figure 9: Europe Oral Market Forecast, 2025-2035 (USD Billion)
Figure 10: Europe Parenteral Market Forecast, 2025-2035 (USD Billion)
Figure 11: Europe Transdermal Market Forecast, 2025-2035 (USD Billion)
Figure 12: Europe Others Market Forecast, 2025-2035 (USD Billion)
Figure 13: Europe Musculoskeletal Market Forecast, 2025-2035 (USD Billion)
Figure 14: Europe Surgical and Trauma Market Forecast, 2025-2035 (USD Billion)
Figure 15: Europe Cancer Market Forecast, 2025-2035 (USD Billion)
Figure 16: Europe Neuropathic Market Forecast, 2025-2035 (USD Billion)
Figure 17: Europe Migraine Market Forecast, 2025-2035 (USD Billion)
Figure 18: Europe Obstetrical Market Forecast, 2025-2035 (USD Billion)
Figure 19: Europe Fibromyalgia Market Forecast, 2025-2035 (USD Billion)
Figure 20: Europe Pain Due to Burns Market Forecast, 2025-2035 (USD Billion)
Figure 21: Europe Dental/Facial Market Forecast, 2025-2035 (USD Billion)
Figure 22: Europe Pediatric Market Forecast, 2025-2035 (USD Billion)
Figure 23: Europe Others Market Forecast, 2025-2035 (USD Billion)
Figure 24: Europe Hospital Pharmacies Market Forecast, 2025-2035 (USD Billion)
Figure 25: Europe Retail Pharmacies Market Forecast, 2025-2035 (USD Billion)
Figure 26: Europe Online Pharmacies Market Forecast, 2025-2035 (USD Billion)
Figure 27: Germany Analgesics Market Forecast, 2025-2035 (USD Billion)
Figure 28: France Analgesics Market Forecast, 2025-2035 (USD Billion)
Figure 29: U.K. Analgesics Market Forecast, 2025-2035 (USD Billion)
Figure 30: Italy Analgesics Market Forecast, 2025-2035 (USD Billion)
Figure 31: Spain Analgesics Market Forecast, 2025-2035 (USD Billion)
Figure 32: Rest of Europe Analgesics Market Forecast, 2025-2035 (USD Billion)

Research Methodology

Related Databooks

March 2026